
Metformin safely lowered maternal glucose levels and cut the risk of neonatal hypoglycemia in pregnant patients receiving antenatal betamethasone.

Metformin safely lowered maternal glucose levels and cut the risk of neonatal hypoglycemia in pregnant patients receiving antenatal betamethasone.

A study found that nonmedically indicated formula supplementation among term infants is common and increasing over time.

New AAP guidance affirms mother’s own milk as optimal for very low birth weight infants, citing reduced NEC and infection risk and outlining donor milk use.

Young adult and adolescent survivors of childhood cancer exhibit accelerated epigenetic aging associated with worse neurocognitive outcomes.

The approval marks the first treatment for this neurodegenerative with a low survival rate beyond 3 years.

Katie McMahon and Kathy Baylis, PhD, discuss research showing that prenatal exposure to hot, humid conditions has significant effects on child growth and health.

Multiple adverse prenatal exposures have been linked to lasting behavioral problems and altered brain development through adolescence.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

Maternal influenza and TDaP vaccination during pregnancy was associated with fewer influenza- and pertussis-related hospital and ED visits in infants younger than 6 months.

Mimi Lee, MD, PhD, noted that broader use of genomic testing could allow pediatric care to move beyond symptom-based diagnoses toward individualized treatment strategies.

The Phase 3 Beeline trial has begun dosing patients to evaluate radiprodil, a targeted NMDA receptor modulator designed to address the underlying biology of GRIN-related neurodevelopmental disorder.

Discover the critical role of physical exams in diagnosing rare conditions like spontaneous pneumomediastinum through unique clinical signs.

Findings from a phase 2 trial showed that once-weekly TransCon CNP plus TransCon hGH produced durable growth and proportionality benefits in children with achondroplasia.

New dietary guidelines stress whole foods and reduced processing, with expanded, age-specific guidance for infants, children, and adolescents.

Shilpa Patel, MD, MPH, says pediatricians can effectively lead asthma care by emphasizing education, trust, and frequent reassessment.

ACIP recommends use of GSK’s pentavalent MenACWY-CRM/MenB-4C vaccine when MenACWY and MenB are indicated at the same visit.

New research shows COVID-19 vaccination before or during pregnancy significantly lowers the risk of severe maternal illness and reduces rates of preterm birth.

New research suggests shorter antimicrobial treatments for pediatric urinary tract infections may be effective, challenging traditional 10-day courses.

GLP-1 receptor agonist use was associated with a lower risk of asthma exacerbations in adolescents with overweight or obesity.

According to Fleischer, epicutaneous immunotherapy represents a “marathon, not a sprint,” with potential long-term benefits when started young.

A survey reveals pediatric providers' limited changes in emergency contraception practices post-Dobbs, highlighting knowledge gaps and barriers to prescribing.

Results from a large randomized trial found that a midpregnancy blood test paired with targeted interventions improved neonatal outcomes in low-risk pregnancies.

New data suggest climate-related heat exposure may influence early developmental trajectories, particularly among vulnerable children.

David Fleischer, MD, says phase 3 VITESSE results show the Viaskin peanut patch offers a safe, practical desensitization option for young children with peanut allergy.

Reactions from the pediatric health care community poured in following swift changes to the US childhood vaccine schedule by the CDC.

FDA approved caplacizumab for pediatric patients ≥12 years with acquired TTP, supported by retrospective data showing 80% remission.

A look back at the FDA submissions and regulatory decisions in the pediatric health care space from December 2025.

With the priority review, the Prescription Drug User Fee Act date is set for April 29, 2026, for potential approval in this younger indication.

Effective immediately, the updated US childhood vaccine schedule will reduce the number of recommended vaccines for all children to 11 diseases, down from 18.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.